Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
Clinical trial NCT04566185 · COMPLETED
Trial details
- NCT number
- NCT04566185
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2023-06-27
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.